Trump is firing federal workers who are not funded by taxpayers
Elon Musk's DOGE team has slashed hundreds of jobs paid for by fees from banks and other forms of funding rather than ...
Senate Democrats press HHS over FDA firings
In letter, senators say recent staff firings could affect drug and device approval, food safety and public health threats.
DOGE Cuts Hit Federal Workers Who Aren’t Funded by Taxpayers
Fees paid to agencies like the Food and Drug Administration and the FDIC fund part of their workforces, so cutting those jobs ...
Top FDA official resigns, warns firings will backfire on RFK Jr.
The top official in charge of food safety and nutrition at the Food and Drug Administration resigned this week, protesting ...
STAT23h
FDA cuts, zombie biotechs, and too much weight loss?
On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...
BioPharma Dive1d
In FDA job cuts, experts see threat of far-reaching impact
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
medtechdive1d
Device industry scrambles as FDA job cuts cause delays
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...
JD Supra1d
Foreign Drug and Medical Device Manufacturers Under a Second Trump Administration: Increased Enforcement Scrutiny?
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...
The Debrief1d
FDA Staff Reviewing Musk’s Neuralink Among Those Fired in DOGE Employee Layoffs
Several U.S. Food and Drug Administration employees connected to reviewing Elon Musk’s brain interface company Neuralink have ...
BioSpace1d
FDA Reels From ‘Indiscriminate’ Job Cuts Under Trump as Biopharma Appeals for Clarity
Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency ...
360dx1d
Staff Cuts at FDA CDRH Could Slow Medical Device Reviews, Stakeholders Warn
In particular, the cuts could hurt the FDA's efforts to scale up its expertise and review capabilities in emerging areas like digital- and AI-based devices.